QBFM
BIIB icon

QS Batterymarch Financial Management’s Biogen BIIB Stock Holding History

QS Batterymarch Financial Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$19.9M Buy
60,299
+12,398
+26% +$4.09M 0.53% 33
2014
Q2 		$15.1M Sell
47,901
-12,465
-21% -$3.75M 0.38% 63
2014
Q1 		$18.5M Buy
60,366
+2,495
+4% +$792K 0.38% 64
2013
Q4 		$16.2M Sell
57,871
-1,784
-3% -$461K 0.34% 69
2013
Q3 		$14.4M Sell
59,655
-1,235
-2% -$276K 0.31% 79
2013
Q2 		$13.1M Buy
+60,890
New +$13M 0.25% 100

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

QS Batterymarch Financial Management's BIIB Position: Q3 2014 in Review

QS Batterymarch Financial Management increased its Biogen (BIIB) stake by 26% in Q3 2014, buying an estimated $4.09M and bringing the position to 60,299 shares worth $19.9M. The position accounts for 0.53% of the portfolio, ranked #33.

QS Batterymarch Financial Management first reported a position in BIIB in Q2 2013 and has held it in 6 quarters since. 818 funds tracked by Wall St. Rank hold BIIB as of Q3 2014.

  • QS Batterymarch Financial Management held 60,299 shares of Biogen worth $19.9M as of Q3 2014.
  • QS Batterymarch Financial Management bought 12,398 Biogen shares in Q3 2014, an estimated $4.09M.
  • Biogen made up 0.53% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #33 holding.
  • QS Batterymarch Financial Management first reported a position in Biogen in Q2 2013 and has held it in 6 quarters since.
  • 818 funds tracked by Wall St. Rank held Biogen as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.